Dual biological effects of the cytokines interleukin-10 and interferon-γ
Open accessThe DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.
Abstract
It is generally thought that each cytokine exerts either immune stimulatory (inflammatory) or immune inhibitory (antiinflammatory or regulatory) biological activities. However, multiple cytokines can enact both inhibitory and stimulatory effects on the immune system. Two of these cytokines are interleukin (IL)-10 and interferon-gamma (IFNγ). IL-10 has demonstrated antitumor immunity even though it has been known for years as an immunoregulatory protein. Generally perceived as an immune stimulatory cytokine, IFNγ can also induce inhibitory molecule expression including B7-H1 (PD-L1), indoleamine 2,3-dioxygenase (IDO), and arginase on multiple cell populations (dendritic cells, tumor cells, and vascular endothelial cells). In this review, we will summarize current knowledge of the dual roles of both of these cytokines and stress the previously underappreciated stimulatory role of IL-10 and inhibitory role of IFNγ in the context of malignancy. Our progressive understanding of the dual effects of these cytokines is important for dissecting cytokine-associated pathology and provides new avenues for developing effective immune therapy against human diseases, including cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hence, IL-10 plays a paradoxical role in cancer immunotherapy through activation or inhibition of IL-10 signaling (73).”
From Gut Microbiome as a Potential Factor for Modulating Resistance to Cancer Immunotherapy (2020) · cites this paper as [73]
Citations
Cites
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
Interleukin-10-deficient mice develop chronic enterocolitis
Kühn, R., Löhler, J., Rennick, D., Rajewsky, K., & Müller, W. (1993) · Cell · doi:10.1016/0092-8674(93)80068-p · Cited by 4,274
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
Fiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.6.2081 · Cited by 2,733
Cloning of a new cytokine that induces IFN-γ production by T cells
Okamura, H., Tsutsui, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., et al. (1995) · Nature · doi:10.1038/378088a0 · Cited by 2,600
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
IL-10: The Master Regulator of Immunity to Infection
Couper, K. N., Blount, D. G., & Riley, E. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.5771 · Cited by 2,223
Regulatory T cells, tumour immunity and immunotherapy
Zou, W. (2006) · Nature Reviews Immunology · doi:10.1038/nri1806 · Cited by 2,085
Self-citationImmunosuppressive networks in the tumour environment and their therapeutic relevance
Zou, W. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1586 · Cited by 2,057
Self-citationNathan, C. F., Murray, H. W., Wiebe, M. E., & Rubin, B. Y. (1983) · The Journal of experimental medicine · doi:10.1084/jem.158.3.670 · Cited by 1,962
de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M. G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.4.915 · Cited by 1,930
Interferons, immunity and cancer immunoediting
Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1961 · Cited by 1,617
Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L., & Powrie, F. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.7.995 · Cited by 1,615
Inhibitory B7-family molecules in the tumour microenvironment
Zou, W., & Chen, L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2326 · Cited by 1,608
Self-citationImmune Response in Mice that Lack the Interferon-γ Receptor
Huang, S., Hendriks, W., Althage, A., Hemmi, S., Bluethmann, H., Kamijo, R., Vilček, J., Zinkernagel, R. M., & Aguet, M. (1993) · Science · doi:10.1126/science.8456301 · Cited by 1,548
Jonuleit, H., Schmitt, E., Schuler, G., Knop, J., & Enk, A. H. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.9.1213 · Cited by 1,538
McGeachy, M. J., Bak-Jensen, K. S., Chen, Y., Tato, C. M., Blumenschein, W., McClanahan, T., & Cua, D. J. (2007) · Nature Immunology · doi:10.1038/ni1539 · Cited by 1,520
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465
Modulation of tryptophan catabolism by regulatory T cells
Fallarino, F., Grohmann, U., Hwang, K. W., Orabona, C., Vacca, C., Bianchi, R., Belladonna, M. L., Fioretti, M. C., Alegre, M.-L., & Puccetti, P. (2003) · Nature Immunology · doi:10.1038/ni1003 · Cited by 1,374
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity
Curiel, T. J., Wei, S., Dong, H., Alvarez, X., Cheng, P., Mottram, P., Krzysiek, R., Knutson, K. L., Daniel, B., Zimmermann, M. C., et al. (2003) · Nature Medicine · doi:10.1038/nm863 · Cited by 1,314
Self-citationRodriguez, P. C., Quiceno, D. G., Zabaleta, J., Ortiz, B., Zea, A. H., Piazuelo, M. B., Delgado, A., Correa, P., Brayer, J., Sotomayor, E. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0465 · Cited by 1,276
Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes
Rousset, F., Garcia, E., Defrance, T., Péronne, C., Vezzio, N., Hsu, D. H., Kastelein, R., Moore, K. W., & Banchereau, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1890 · Cited by 1,238
A Mutation in the Interferon-γ –Receptor Gene and Susceptibility to Mycobacterial Infection
Newport, M. J., Huxley, C. M., Huston, S., Hawrylowicz, C. M., Oostra, B. A., Williamson, R., & Levin, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352602 · Cited by 1,199
Interleukin‐10: new perspectives on an old cytokine
Mosser, D. M., & Zhang, X. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00706.x · Cited by 1,077
Muller, A. J., DuHadaway, J. B., Donover, P. S., Sutanto-Ward, E., & Prendergast, G. C. (2005) · Nature Medicine · doi:10.1038/nm1196 · Cited by 1,064
Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase
Munn, D. H., Sharma, M. D., Lee, J. R., Jhaver, K. G., Johnson, T. S., Keskin, D. B., Marshall, B., Chandler, P., Antonia, S. J., Burgess, R., et al. (2002) · Science · doi:10.1126/science.1073514 · Cited by 1,028
MAST CELLS AS “TUNABLE” EFFECTOR AND IMMUNOREGULATORY CELLS: Recent Advances
Galli, S. J., Kalesnikoff, J., Grimbaldeston, M. A., Piliponsky, A. M., Williams, C. M. M., & Tsai, M. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141025 · Cited by 1,017
The roles of IFNγ in protection against tumor development and cancer immunoediting
Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00038-7 · Cited by 899
Quiescent haematopoietic stem cells are activated by IFN-γ in response to chronic infection
Baldridge, M. T., King, K. Y., Boles, N. C., Weksberg, D. C., & Goodell, M. A. (2010) · Nature · doi:10.1038/nature09135 · Cited by 877
Carnaud, C., Lee, D., Donnars, O., Park, S.-H., Beavis, A., Koezuka, Y., & Bendelac, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.9.4647 · Cited by 854
Zea, A. H., Rodriguez, P. C., Atkins, M. B., Hernandez, C., Signoretti, S., Zabaleta, J., McDermott, D., Quiceno, D., Youmans, A., O'Neill, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4505 · Cited by 851
Murai, M., Turovskaya, O., Kim, G., Madan, R., Karp, C. L., Cheroutre, H., & Kronenberg, M. (2009) · Nature Immunology · doi:10.1038/ni.1791 · Cited by 850
Gajewski, T. F., & Fitch, F. W. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.12.4245 · Cited by 834
Ding, L., Linsley, P. S., Huang, L. Y., Germain, R. N., & Shevach, E. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.3.1224 · Cited by 829
Kryczek, I., Banerjee, M., Cheng, P., Vatan, L., Szeliga, W., Wei, S., Huang, E., Finlayson, E., Simeone, D., Welling, T. H., et al. (2009) · Blood · doi:10.1182/blood-2009-03-208249 · Cited by 813
Self-citationSharma, M. D., Baban, B., Chandler, P., Hou, D.-Y., Singh, N., Yagita, H., Azuma, M., Blazar, B. R., Mellor, A. L., & Munn, D. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31911 · Cited by 792
Rodriguez, P. C., Ernstoff, M. S., Hernandez, C., Atkins, M., Zabaleta, J., Sierra, R., & Ochoa, A. C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1921 · Cited by 773
Yoshimoto, T., Takeda, K., Tanaka, T., Ohkusu, K., Kashiwamura, S., Okamura, H., Akira, S., & Nakanishi, K. (1998) · PubMed · Cited by 770
IFN- gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses.
Finkelman, F. D., Katona, I. M., Mosmann, T. R., & Coffman, R. L. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.4.1022 · Cited by 723
Robinson, D., Shibuya, K., Mui, A., Zonin, F., Murphy, E., Sana, T., Hartley, S. B., Menon, S., Kastelein, R., Bazan, F., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80378-7 · Cited by 720
Rodríguez, P. C., & Ochoa, A. C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00608.x · Cited by 719
Hesse, M., Modolell, M., La Flamme, A. C., Schito, M., Fuentes, J. M., Cheever, A. W., Pearce, E. J., & Wynn, T. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6533 · Cited by 706
Chin, Y. E., Kitagawa, M., Su, W.-C. S., You, Z.-H., Iwamoto, Y., & Fu, X.-Y. (1996) · Science · doi:10.1126/science.272.5262.719 · Cited by 696
Myeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism
Mazzoni, A., Bronte, V., Visintin, A., Spitzer, J. H., Apolloni, E., Serafini, P., Zanovello, P., & Segal, D. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.689 · Cited by 690
Yoshimoto, T., Takeda, K., Tanaka, T., Ohkusu, K., Kashiwamura, S.-I., Okamura, H., Akira, S., & Nakanishi, K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3400 · Cited by 675
Biochemical characterization of a gamma interferon-inducible cytokine (IP-10).
Luster, A. D., & Ravetch, J. V. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.4.1084 · Cited by 666
Dighe, A. S., Richards, E., Old, L. J., & Schreiber, R. D. (1994) · Immunity · doi:10.1016/1074-7613(94)90087-6 · Cited by 663
TH17 cells in tumour immunity and immunotherapy
Zou, W., & Restifo, N. P. (2010) · Nature Reviews Immunology · doi:10.1038/nri2742 · Cited by 624
Self-citationMunder, M., Mallo, M., Eichmann, K., & Modolell, M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.2103 · Cited by 600
Liu, J., Hamrouni, A., Wolowiec, D., Coiteux, V., Kuliczkowski, K., Hetuin, D., Saudemont, A., & Quesnel, B. (2007) · Blood · doi:10.1182/blood-2006-10-051482 · Cited by 580
Perforin and interferon-γ activities independently control tumor initiation, growth, and metastasis
Street, S. E. A., Cretney, E., & Smyth, M. J. (2001) · Blood · doi:10.1182/blood.v97.1.192 · Cited by 572
Modolell, M., Corraliza, I. M., Link, F., Soler, G., & Eichmann, K. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250436 · Cited by 554
Llorente, L., Zou, W., Levy, Y., Richaud-Patin, Y., Wijdenes, J., Alcocer-Varela, J., Morel-Fourrier, B., Brouet, J. C., Alarcon-Segovia, D., Galanaud, P., et al. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.839 · Cited by 541
Self-citationScott, P. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.9.3149 · Cited by 524
Steinbrink, K., Jonuleit, H., Müller, G., Schuler, G., Knop, J., & Enk, A. H. (1999) · Blood · doi:10.1182/blood.v93.5.1634 · Cited by 511
Jouanguy, E., Lamhamedi-Cherradi, S., Lammas, D., Dorman, S. E., Fondanèche, M.-C., Dupuis, S., Döffinger, R., Altare, F., Girdlestone, J., Emile, J.-F., et al. (1999) · Nature Genetics · doi:10.1038/7701 · Cited by 492
Huang, M., Stolina, M., Sharma, S. P., Mao, J. T., Zhu, L. X., Miller, P. W., Wollman, J. S., Herschman, H. R., & Dubinett, S. M. (1998) · PubMed · Cited by 492
l -Arginine Consumption by Macrophages Modulates the Expression of CD3ζ Chain in T Lymphocytes
Rodriguez, P. C., Zea, A. H., DeSalvo, J., Culotta, K. S., Zabaleta, J., Quiceno, D. G., Ochoa, J. B., & Ochoa, A. C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1232 · Cited by 492
Arginase, Prostaglandins, and Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma
Ochoa, A. C., Zea, A. H., Hernandez, C., & Rodriguez, P. C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2197 · Cited by 489
REGULATION OF MHC CLASS II GENES: Lessons from a Disease
Mach, B., Steimle, V., Martinez-Soria, E., & Reith, W. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.301 · Cited by 486
Grimbaldeston, M. A., Nakae, S., Kalesnikoff, J., Tsai, M., & Galli, S. J. (2007) · Nature Immunology · doi:10.1038/ni1503 · Cited by 485
Regulation of Interleukin 12 p40 Expression through an NF-κB Half-Site
Murphy, T. L., Cleveland, M. G., Kulesza, P., Magram, J., & Murphy, K. M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5258 · Cited by 482
Go, N. F., Castle, B. E., Barrett, R., Kastelein, R., Dang, W., Mosmann, T. R., Moore, K. W., & Howard, M. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.6.1625 · Cited by 475
Kryczek, I., Bruce, A. T., Gudjonsson, J. E., Johnston, A., Aphale, A., Vatan, L., Szeliga, W., Wang, Y., Liu, Y., Welling, T. H., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4733 · Cited by 470
Self-citationHighfill, S. L., Rodriguez, P. C., Zhou, Q., Goetz, C. A., Koehn, B. H., Veenstra, R., Taylor, P. A., Panoskaltsis-Mortari, A., Serody, J. S., Munn, D. H., et al. (2010) · Blood · doi:10.1182/blood-2010-06-287839 · Cited by 465
Stolina, M., Sharma, S., Lin, Y., Dohadwala, M., Gardner, B., Luo, J., Zhu, L., Kronenberg, M., Miller, P. W., Portanova, J., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.361 · Cited by 465
Regulation of Antigen-Specific CD8 + T Cell Homeostasis by Perforin and Interferon-γ
Badovinac, V. P., Tvinnereim, A. R., & Harty, J. T. (2000) · Science · doi:10.1126/science.290.5495.1354 · Cited by 438
Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN- gamma .
Billiau, A., Heremans, H., Vandekerckhove, F., Dijkmans, R., Sobis, H., Meulepas, E., & Carton, H. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.5.1506 · Cited by 435
Liu, Y., Mason, D. Y., Johnson, G. D., Abbot, S., Gregory, C. D., Hardie, D. L., Gordon, J., & MacLennan, I. C. M. (1991) · European Journal of Immunology · doi:10.1002/eji.1830210819 · Cited by 435
Bromberg, J. F., Horvath, C. M., Wen, Z., Schreiber, R. D., & Darnell, J. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7673 · Cited by 422
Morel, S., Lévy, F., Burlet-Schiltz, O., Brasseur, F., Probst-Kepper, M., Peitrequin, A.-L., Monsarrat, B., Van Velthoven, R., Cerottini, J.-C., Boon, T., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)80163-6 · Cited by 415
Coughlin, C. M., Salhany, K. E., Wysocka, M., Aruga, E., Kurzawa, H., Chang, A. E., Hunter, C. A., Fox, J. C., Trinchieri, G., & Lee, W. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1555 · Cited by 415
Virus interference. II. Some properties of interferon
Isaacs, A., Lindenmann, J., & Valentine, R. C. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0049 · Cited by 413
IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo.
Luster, A. D., & Leder, P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.3.1057 · Cited by 407
Davidson, N. J., Leach, M. W., Fort, M. M., Thompson-Snipes, L., Kühn, R., Müller, W., Berg, D. J., & Rennick, D. M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.1.241 · Cited by 402
Interleukin-10 and the immune response against cancer: a counterpoint
Mocellin, S., Marincola, F. M., & Young, H. A. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0705358 · Cited by 402
Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma
Enk, A. H., Jonuleit, H., Saloga, J., & Knop, J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19971104)73:3<309::aid-ijc1>3.0.co;2-3 · Cited by 386
Preferential effect of γ interferon on the synthesis of HLA antigens and their mRNAs in human cells
Wallach, D., Fellous, M., & Revel, M. (1982) · Nature · doi:10.1038/299833a0 · Cited by 383
IL-10: a novel cytotoxic T cell differentiation factor
Chen, W. F., & Zlotnik, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.2.528 · Cited by 382
Yoshimoto, T., Okamura, H., Tagawa, Y.-I., Iwakura, Y., & Nakanishi, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3948 · Cited by 381
Wu, K., Kryczek, I., Chen, L., Zou, W., & Welling, T. H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0901 · Cited by 380
Self-citationPlasmacytoid Dendritic Cells Induce CD8+ Regulatory T Cells In Human Ovarian Carcinoma
Wei, S., Kryczek, I., Zou, L., Daniel, B., Cheng, P., Mottram, P., Curiel, T., Lange, A., & Zou, W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4043 · Cited by 379
Self-citationInhibitory and Stimulatory Effects of IL-10 on Human CD8+ T Cells
Groux, H., Bigler, M., de Vries, J. E., & Roncarolo, M.-G. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3188 · Cited by 376
IL-10, a novel growth cofactor for mature and immature T cells.
MacNeil, I. A., Suda, T., Moore, K. W., Mosmann, T. R., & Zlotnik, A. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.4167 · Cited by 360
Kusmartsev, S. A., Li, Y., & Chen, S.-H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.779 · Cited by 355
Arenberg, D. A., Kunkel, S. L., Polverini, P. J., Morris, S. B., Burdick, M. D., Glass, M. C., Taub, D. T., Iannettoni, M. D., Whyte, R. I., & Strieter, R. M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.981 · Cited by 353
Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10
O'Garra, A., Stapleton, G., Dhar, V., Pearce, M., Schumacher, J., Rugo, H., Barbls, D., Stall, A., Cupp, J., Moore, K., et al. (1990) · International Immunology · doi:10.1093/intimm/2.9.821 · Cited by 344
Vicari, A. P., Chiodoni, C., Vaure, C., Aït-Yahia, S., Dercamp, C., Matsos, F., Reynard, O., Taverne, C., Merle, P., Colombo, M. P., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020732 · Cited by 343
Levy, Y., & Brouet, J. C. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116977 · Cited by 340
van der Sluijs, K. F., van Elden, L. J. R., Nijhuis, M., Schuurman, R., Pater, J. M., Florquin, S., Goldman, M., Jansen, H. M., Lutter, R., & van der Poll, T. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7603 · Cited by 334
IL-12 synergizes with IL-18 or IL-1β for IFN-γ production from human T cells
Tominaga, K., Yoshimoto, T., Torigoe, K., Kurimoto, M., Matsui, K., Hada, T., Okamura, H., & Nakanishi, K. (2000) · International Immunology · doi:10.1093/intimm/12.2.151 · Cited by 333
Interferon-γ acts directly on CD8+ T cells to increase their abundance during virus infection
Whitmire, J. K., Tan, J. T., & Whitton, J. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041463 · Cited by 331
Creating immune privilege: active local suppression that benefits friends, but protects foes
Mellor, A. L., & Munn, D. H. (2008) · Nature Reviews Immunology · doi:10.1038/nri2233 · Cited by 327
Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells
Eberl, G., & MacDonald, H. R. (2000) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(200004)30:4<985::aid-immu985>3.0.co;2-e · Cited by 326
Coughlin, C. M., Salhany, K. E., Gee, M. S., LaTemple, D. C., Kotenko, S., Ma, X., Gri, G., Wysocka, M., Kim, J. E., Liu, L., et al. (1998) · Immunity · doi:10.1016/s1074-7613(00)80585-3 · Cited by 324
Kim, J., Modlin, R. L., Moy, R. L., Dubinett, S. M., McHugh, T., Nickoloff, B. J., & Uyemura, K. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.4.2240 · Cited by 323
A direct role for IFN-γ in regulation of Th1 cell development
Bradley, L. M., Dalton, D. K., & Croft, M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.4.1350 · Cited by 319
De Santo, C., Arscott, R., Booth, S., Karydis, I., Jones, M., Asher, R., Salio, M., Middleton, M., & Cerundolo, V. (2010) · Nature Immunology · doi:10.1038/ni.1942 · Cited by 304
Interferon-γ links ultraviolet radiation to melanomagenesis in mice
Zaidi, M. R., Davis, S., Noonan, F. P., Graff-Cherry, C., Hawley, T. S., Walker, R. L., Feigenbaum, L., Fuchs, E., Lyakh, L., Young, H. A., et al. (2011) · Nature · doi:10.1038/nature09666 · Cited by 293
Norian, L. A., Rodriguez, P. C., O'Mara, L. A., Zabaleta, J., Ochoa, A. C., Cella, M., & Allen, P. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2826 · Cited by 270
Altered Immune Responses in Interleukin 10 Transgenic Mice
Hagenbaugh, A., Sharma, S., Dubinett, S. M., Wei, S. H.-Y., Aranda, R., Cheroutre, H., Fowell, D. J., Binder, S., Tsao, B., Locksley, R. M., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.12.2101 · Cited by 269
Self-citationTumor cyclooxygenase 2-dependent suppression of dendritic cell function.
Sharma, S. P., Stolina, M., Yang, S.-C., Baratelli, F. E., Lin, J. F.-H., Atianzar, K., Luo, J., Zhu, L., Lin, Y., Huang, M., et al. (2003) · PubMed · Cited by 255
B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10.
Schandené, L., Alonso-Vega, C., Willems, F., Gérard, C., Delvaux, A., Velu, T., Devos, R., de Boer, M., & Goldman, M. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.9.4368 · Cited by 251
Mig, the Monokine Induced By Interferon-γ, Promotes Tumor Necrosis In Vivo
Sgadari, C., Farber, J. M., Angiolillo, A. L., Liao, F., Teruya-Feldstein, J., Burd, P. R., Yao, L., Gupta, G., Kanegane, C., & Tosato, G. (1997) · Blood · doi:10.1182/blood.v89.8.2635 · Cited by 246
Muller, A. J., Sharma, M. D., Chandler, P. R., DuHadaway, J. B., Everhart, M. E., Johnson, B. A., Kahler, D. J., Pihkala, J., Soler, A. P., Munn, D. H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806173105 · Cited by 240
Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism.
Zheng, L. M., Ojcius, D. M., Garaud, F., Roth, C., Maxwell, E., Li, Z., Rong, H., Chen, J., Wang, X. Y., Catino, J. J., et al. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.579 · Cited by 230
Levin, M., Newport, M. J., Kalabalikis, P., Klein, N., D'Souza, S., Brown, I. N., Lenicker, H. M., Vassallo Agius, P., Davies, E. G., Thrasher, A., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90059-4 · Cited by 217
Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo
Sgadari, C., Angiolillo, A. L., Cherney, B. W., Pike, S. E., Farber, J. M., Koniaris, L. G., Vanguri, P., Burd, P. R., Sheikh, N., Gupta, G., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13791 · Cited by 217
Interleukin-10 promotes the maintenance of antitumor CD8+ T-cell effector function in situ
Fujii, S.-I., Shimizu, K., Shimizu, T., & Lotze, M. T. (2001) · Blood · doi:10.1182/blood.v98.7.2143 · Cited by 208
Kondo, A., Yamashita, T., Tamura, H., Zhao, W., Tsuji, T., Shimizu, M., Shinya, E., Takahashi, H., Tamada, K., Chen, L., et al. (2010) · Blood · doi:10.1182/blood-2009-12-255125 · Cited by 201
Feng, T., Qin, H., Wang, L., Benveniste, E. N., Elson, C. O., & Cong, Y. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001454 · Cited by 199
Self-citationDemangel, C., Bertolino, P., & Britton, W. J. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200204)32:4<994::aid-immu994>3.0.co;2-6 · Cited by 196
Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand
Mages, H. W., Hutloff, A., Heuck, C. J., Büchner, K., Himmelbauer, H., Oliveri, F., & Kroczek, R. A. (2000) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(200004)30:4<1040::aid-immu1040>3.0.co;2-6 · Cited by 195
Suzuki, T., Tahara, H., Narula, S., Moore, K. W., Robbins, P. D., & Lotze, M. T. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.477 · Cited by 185
Xaus, J., Cardó, M., Valledor, A. F., Soler, C., Lloberas, J., & Celada, A. (1999) · Immunity · doi:10.1016/s1074-7613(00)80085-0 · Cited by 182
Interferon affects both G1 and S+G2 in cells stimulated from quiescence to growth
BALKWILL, F., & TAYLOR-PAPADIMITRIOU, J. (1978) · Nature · doi:10.1038/274798a0 · Cited by 181
Interleukin-10 Ablation Promotes Tumor Development, Growth, and Metastasis
Tanikawa, T., Wilke, C. M., Kryczek, I., Chen, G. Y., Kao, J., Núñez, G., & Zou, W. (2012) · Cancer Research · doi:10.1158/0008-5472.can-10-4627 · Cited by 174
Self-citationLoercher, A. E., Nash, M. A., Kavanagh, J. J., Platsoucas, C. D., & Freedman, R. S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.6251 · Cited by 173
Berner, V., Liu, H., Zhou, Q., Alderson, K. L., Sun, K., Weiss, J. M., Back, T. C., Longo, D. L., Blazar, B. R., Wiltrout, R. H., et al. (2007) · Nature Medicine · doi:10.1038/nm1554 · Cited by 161
Jarry, A., Bossard, C., Bou‐Hanna, C., Masson, D., Espaze, E., Denis, M. G., & LABOISSE, C. L. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32140 · Cited by 158
Saio, M., Radoja, S., Marino, M., & Frey, A. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5583 · Cited by 157
Interleukin‐10 provides direct trophic support to neurons
Zhou, Z., Peng, X., Insolera, R., Fink, D. J., & Mata, M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06263.x · Cited by 156
Carlin, J. M., Borden, E. C., Sondel, P. M., & Byrne, G. I. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.7.2414 · Cited by 154
Transcriptional regulation of the MHC class Ib genes HLA-E, HLA-F, and HLA-G
Gobin, S. J. P., & van den Elsen, P. J. (2000) · Human Immunology · doi:10.1016/s0198-8859(00)00198-1 · Cited by 152
Interferon-γ inducible exchanges of 20S proteasome active site subunits: Why?
Groettrup, M., Khan, S., Schwarz, K., & Schmidtke, G. (2001) · Biochimie · doi:10.1016/s0300-9084(01)01251-2 · Cited by 147
Dace, D. S., Khan, A. A., Kelly, J., & Apte, R. S. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003381 · Cited by 146
Park, H.-J., Lee, S. J., Kim, S. H., Han, J., Bae, J., Kim, S. J., Park, C., & Chun, T. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.10.020 · Cited by 142
Interleukin-10 Inhibits Tumor Metastasis, Downregulates MHC Class I, and Enhances NK Lysis
Kundu, N., & Fulton, A. M. (1997) · Cellular Immunology · doi:10.1006/cimm.1997.1176 · Cited by 141
Khoo, U. Y., Proctor, I. E., & Macpherson, A. J. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.8.3626 · Cited by 141
Immune privilege in sites of chronic infection: Leishmania and regulatory T cells
Peters, N., & Sacks, D. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00432.x · Cited by 132
HLA-G and IL-10 expression in human cancer—different stories with the same message
Urosevic, M., & Dummer, R. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(03)00024-5 · Cited by 128
Role for Gamma Interferon in Control of Herpes Simplex Virus Type 1 Reactivation
Cantin, E., Tanamachi, B., & Openshaw, H. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.3418-3423.1999 · Cited by 127
IFN-γ Induces IL-12 mRNA Expression by a Murine Macrophage Cell Line, J774
Yoshida, A., Koide, Y., Uchijima, M., & Yoshida, T. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1122 · Cited by 123
Giordanengo, L., Guiñazú, N. L., Stempin, C. C., Fretes, R., Cerbán, F. M., & Gea, S. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200204)32:4<1003::aid-immu1003>3.0.co;2-p · Cited by 123
Taniguchi, K., Petersson, M., Höglund, P., Kiessling, R., Klein, G., & Kärre, K. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3405 · Cited by 114
Wiendl, H., Mitsdoerffer, M., Schneider, D., Chen, L., Lochmüller, H., Melms, A., & Weller, M. (2003) · The FASEB Journal · doi:10.1096/fj.03-0039fje · Cited by 109
Meyskens, F. L., Kopecky, K. J., Taylor, C. W., Noyes, R. D., Tuthill, R. J., Hersh, E. M., Feun, L. G., Doroshow, J. H., Flaherty, L. E., & Sondak, V. K. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.22.1710 · Cited by 109
Cutting Edge: Differentiation of Antitumor CTL In Vivo Requires Host Expression of Stat1
Fallarino, F., & Gajewski, T. F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4109 · Cited by 106
Johnson, D. R., & Pober, J. S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5183 · Cited by 102
Cao, X., Leonard, K., Collins, L. I., Cai, S. F., Mayer, J. C., Payton, J. E., Walter, M. J., Piwnica-Worms, D. R., Schreiber, R. D., & Ley, T. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1145 · Cited by 96
Garbe, C., Krasagakis, K., Zouboulis, C. C., Schröder, K., Krüger, S., Stadler, R., & Orfanos, C. E. (1990) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12875837 · Cited by 92
Cutting Edge: IFN-γ Enables APC to Promote Memory Th17 and Abate Th1 Cell Development
Kryczek, I., Wei, S., Gong, W., Shu, X., Szeliga, W., Vatan, L., Chen, L., Wang, G., & Zou, W. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.5842 · Cited by 91
Self-citationTissue-specific targeting of gytokine unresponsiveness in transgenic mice
Dighe, A. S., Campbell, D., Hsieh, C.-S., Clarke, S., Greaves, D. R., Gordon, S., Murphy, K. M., & Schreiber, R. D. (1995) · Immunity · doi:10.1016/1074-7613(95)90136-1 · Cited by 90
Kurte, M., López, M., Aguirre, A., Escobar, A., Aguillón, J. C., Charo, J., Larsen, C. G., Kiessling, R., & Salazar-Onfray, F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.1731 · Cited by 86
Spontaneous Rejection of Poorly Immunogenic P1.HTR Tumors by Stat6-Deficient Mice
Kacha, A. K., Fallarino, F., Markiewicz, M. A., & Gajewski, T. F. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6024 · Cited by 86
Autocrine Secretion of Interferon γ Negatively Regulates Homing of Immature B Cells
Flaishon, L., Hershkoviz, R., Lantner, F., Lider, O., Alon, R., Levo, Y., Flavell, R. A., & Shachar, I. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.9.1381 · Cited by 81
Regulation of cytokine receptor signaling by SOCS1
Ilangumaran, S., & Rottapel, R. K. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00020.x · Cited by 81
A cancer immunosurveillance controversy
Qin, Z., & Blankenstein, T. J. F. (2003) · Nature Immunology · doi:10.1038/ni0104-3 · Cited by 79
Briesemeister, D., Sommermeyer, D., Loddenkemper, C., Loew, R., Uckert, W., Blankenstein, T., & Kammertoens, T. (2011) · International Journal of Cancer · doi:10.1002/ijc.25350 · Cited by 68
MEYSKENS, F. L., KOPECKY, K., SAMSON, M., HERSH, E., MACDONALD, J., JAFFE, H., CROWLEY, J., & COLTMAN, C. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.12.1071-a · Cited by 66
A critical analysis of the tumour immunosurveillance controversy for 3-MCA-induced sarcomas
Schreiber, T. H., & Podack, E. R. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605198 · Cited by 66
Administration of interleukin‐10 abolishes innate resistance to Listeria monocytogenes
Kelly, J. P., & Bancroft, G. J. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260214 · Cited by 63
Interferon γ limits the effectiveness of melanoma peptide vaccines
Cho, H.-I., Lee, Y.-R., & Celis, E. (2011) · Blood · doi:10.1182/blood-2010-08-298117 · Cited by 60
Importance of Interleukin-10 in Genetic Susceptibility of Mice to Coccidioides immitis
Fierer, J., Walls, L., Eckmann, L., Yamamoto, T., & Kirkland, T. N. (1998) · Infection and Immunity · doi:10.1128/.66.9.4397-4402.1998 · Cited by 55
Ernstoff, M. S., Trautman, T., Davis, C. A., Reich, S. D., Witman, P., Balser, J., Rudnick, S., & Kirkwood, J. M. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.11.1804 · Cited by 54
Matar, P., Rozados, V. R., Gervasoni, S. I., & Scharovsky, O. G. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(00)00028-x · Cited by 53
Importance of IL-10 for CTLA-4-Mediated Inhibition of Tumor-Eradicating Immunity
Jovasevic, V. M., Gorelik, L., Bluestone, J. A., & MOKYR, M. B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1449 · Cited by 46
IL-10 modulates intestinal damage and epithelial cell apoptosis in T cell-mediated enteropathy
Zhou, P., Streutker, C. J., Borojevic, R., Wang, Y., & Croitoru, K. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00063.2004 · Cited by 46
Seo, N., Hayakawa, S., & TOKURA, Y. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00015-9 · Cited by 42
Phase II study of recombinant interferon-gamma in patients with disseminated malignant melanoma.
Et, C., Ahmann, D. L., Long, H. J., Frytak, S., Sherwin, S. A., & Mn, C. (1987) · PubMed · Cited by 41
Jiménez, M. D. P., Walls, L., & Fierer, J. (2006) · Infection and Immunity · doi:10.1128/iai.01985-05 · Cited by 40
Chemical Carcinogens as Foreign Bodies and Some Pitfalls Regarding Cancer Immune Surveillance
Blankenstein, T. J. F., & Qin, Z. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)90006-6 · Cited by 38
Natural killer cells and the MHC class I pathway of peptide presentation
Kärre, K. (1993) · Seminars in Immunology · doi:10.1006/smim.1993.1016 · Cited by 35
Starr, R., Fuchsberger, M., Lau, L. S., Uldrich, A. P., Goradia, A., Willson, T. A., Verhagen, A. M., Alexander, W. S., & Smyth, M. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901010 · Cited by 35
Shiohara, M., Koike, K., & NAKAHATA, T. (1993) · Blood · doi:10.1182/blood.v81.6.1435.1435 · Cited by 35
Kim, B.-G., Joo, H., Chung, I.-S., Chung, H. Y., Woo, H.-J., & Yun, Y. (2000) · Cancer Immunology Immunotherapy · doi:10.1007/s002620000123 · Cited by 34
Liscovsky, M. V., Ranocchia, R. P., Gorlino, C. V., Alignani, D., Morón, G., Maletto, B. A., & Pistoresi-Palencia, M. C. (2009) · Immunology · doi:10.1111/j.1365-2567.2008.02938.x · Cited by 31
Immunomodulatory Effects of Interferon-?? in Patients with Metastatic Malignant Melanoma
Kopp, W. C., Smith, J. W., Ewel, C., Alvord, W. G., Main, C., Guyre, P. M., Steis, R. G., Longo, D. L., & Urba, W. J. (1993) · Journal of Immunotherapy · doi:10.1097/00002371-199304000-00005 · Cited by 23
The role of interferon-gamma in the induction of activated macrophages
Schreiber, R. D., Celada, A., & Buchmeier, N. A. (1986) · Annales de l Institut Pasteur Immunologie · doi:10.1016/s0771-050x(86)80028-6 · Cited by 22
Kowalzick, L., Weyer, U., Lange, P., & Breitbart, E. W. (2009) · Dermatologica · doi:10.1159/000247830 · Cited by 15
Tsuchihashi (2000) · doi:10.1002/1521-4141(200006)30:6
Research works printed but not linked: 1
- Joss A, Akdis M, Faith A, Blaser K, Akdis CA (2000) IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway. Eur J Immunol 30(6):1683–1690 · doi:10.1002/1521-4141(200006)30:6<1683::aid-immu1683>3.0.co;2-a
Cited by
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
Topalian, S. L., Drake, C. G., & Pardoll, D. M. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.12.009 · Cited by 1,329
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
Akinleye, A., & Rasool, Z. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0779-5 · Cited by 733
Carlini, V., Noonan, D. M., Abdalalem, E., Goletti, D., Sansone, C., Calabrone, L., & Albini, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1161067 · Cited by 543
Li, H., Wu, K., Tao, K., Chen, L., Zheng, Q., Lu, X., Liu, J., Shi, L., Liu, C., Wang, G., et al. (2012) · Hepatology · doi:10.1002/hep.25777 · Cited by 496
Self-citation
Metadata
- Authors
- Wilke, C. M., Wei, S., Wang, L., Kryczek, I., Kao, J., & Zou, W.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Zou, Weiping
- Venue
- Cancer Immunology Immunotherapy
- Published
- 2011-09-15
- Volume
- 60
- Issue
- 11
- Pages
- 1529-1541
- ISSN
- 0340-7004 (ISSN-L)
- 1432-0851
- PMC
- PMC11029274
- OpenAlex
- W1977523238
- Cited by
- 138
- References
- 172
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 9 · 2023: 10 · 2022: 8 · 2021: 11 · 2020: 10 · 2019: 16 · 2018: 9 · 2017: 5 · 2016: 8 · 2015: 8 · 2014: 11 · 2013: 8 · 2012: 12
- FWCI
- 5.36
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Cancer Immunology Immunotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Michigan
- National Institutes of Health
- National Cancer Institute (P30-CA 46592, P30CA046592)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- IL-10, interferon-gamma, antitumor immunity, immune regulation, PD-L1, indoleamine 2,3-dioxygenase, arginase, tumor-associated macrophages, dendritic cells, cancer immunotherapy, immune checkpoint molecules
- MeSH terms
- Animals, Humans, Inflammation, Interferon-gamma, Neoplasms, Interleukin-10
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.